Related Party Transactions (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Jun. 13, 2024 |
Apr. 01, 2024 |
Nov. 15, 2023 |
Jun. 30, 2022 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Jan. 18, 2024 |
|
| Related party advances, net | $ 100,000 | $ 75,000 | |||||||
| Purchase shares cancellation | 400,000 | ||||||||
| Common stock per share | $ 19.94 | ||||||||
| Accrued expenses | 736,407 | $ 2,439,794 | $ 223,535 | ||||||
| Advance from related party | 100,000 | $ 0 | |||||||
| Loan amount | $ 1,500,000 | ||||||||
| Interest rate | 8.50% | ||||||||
| Additional PIK | 3.50% | ||||||||
| Stock Purchase Agreement [Member] | |||||||||
| Purchase price for the stock | $ 6,000,000 | 6,000,000 | |||||||
| Mr. Marshall [Member] | |||||||||
| Common stock share purchase | 18,750 | 125,000 | 400,000 | ||||||
| Related party advances, net | 500,000 | $ 75,000 | $ 500,000 | ||||||
| Description of amendment to the promissory note | the Company executed an amendment to the promissory note with Mr. Marshall, providing for the payment of interest only for 18 months at an interest rate of 12% per annum and thereafter, the amortization of the note over a 12-month period, starting in June of 2025. $1,000,000 of the principal was used as part of the VitaMedica purchase price | ||||||||
| Common stock per share | $ 22.00 | $ 2.60 | |||||||
| Accrued interest | 169,662 | $ 30,760 | |||||||
| Principal amount used | $ 1,000,000 | ||||||||
| MFA 2510 Merchant LLC [Member] | Lease Agreement [Member] | |||||||||
| Leasehold improvements expenses | $ 611,768 | ||||||||
| Accrued expenses | 100,004 | ||||||||
| Lease rent, per month | $ 20,060 | ||||||||
| Lease term | 5 years | ||||||||